Perma Fix Medical SA (WSE:PFM) announced that it has signed a letter of intent for a private placement of 71,429 series F shares at a price of PLN 53 per share with new investor Digirad Corporation for gross proceeds of PLN 3,785,737 on January 15, 2015. As a part of the round, the investor will acquire a total of 5.4% stake in the company. The investor will have the right to appoint one member to the company's supervisory board, and a second appointee to either the supervisory board or the management team. The transaction is subject to numerous conditions, including, but not limited to, entering into definitive supply, stock purchase and other agreements, approval by the boards of company and investor and obtaining required approvals by Polish regulatory authorities as to issuance of the shares to investor.

On July 27, 2015, Perma Fix Medical SA closed the transaction. The company entered into strategic partnership with the investor.